京新藥業(002020.SZ):中藥板塊在公司扮演了非常重要的角色
格隆匯8月16日丨有投資者向京新藥業(002020.SZ)提問:公司對中藥板塊佈局的考慮?
京新藥業回覆:中藥板塊在公司扮演了非常重要的角色,是公司的一個戰略資產。其一,內蒙中藥生產基地預計今年年內產能釋放,解決了中藥的產能瓶頸;其二,在產能後盾的基礎上,公司加強中藥重點銷售地區自營團隊的建設和推廣力度,有利於釋放產品活力;其三,在產能後盾的基礎上,公司會陸續復產批文庫中優勢品種,豐富產品庫,與化藥形成銷售合力,推動院外連鎖藥店的合作。未來我們認為中藥的業績會持續穩定增長。謝謝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.